CClinicalTrials.gg
CompletedNCT00494793Updated Dec 29, 2017

Vacuum Assisted Wound Closure (VAWC) and Mesh Mediated Fascial Traction

An interventional study of VAWC and mesh mediated fascial traction in Open Abdomen and Fascial Closure, sponsored by Skane University Hospital. Completed at 5 sites in Sweden. Per ClinicalTrials.gov, last updated 2017-12-29.

Sponsored by Skane University Hospital · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 1 year 2 months after the study started (first participant enrolled Apr 2006, registered Jun 2007).
Phase
Not applicable
Study type
Interventional
Enrollment
111
Allocation
Not applicable
Sex
All
01

Study summary

The purpose of this multicenter trial is to prospectively evaluate a novel combination of vacuum assisted wound closure (VAWC) and mesh mediated fascial traction for closure of open abdomens.

Read the detailed description

Open abdomen treatment often results in difficulties in closing the abdomen. Highest closure rates are seen with the vacuum assisted wound closure (VAWC) technique. Failures with this technique is occasionally experienced, especially in cases with severe visceral swelling needing longer treatment periods with open abdomen. A novel combination of vacuum assisted wound closure and mesh mediated fascial traction for managing the open abdomen was therefore developed and initially tested in a small pilot-like study with encouraging results with late primary closure of the abdomens in all seven patients.

In this multicenter study we prospectively evaluate the technique.

Inclusion criteria:

All patients treated with open abdomen at the 4 participating hospitals are registered, and only those patients who have commenced therapy with VAWC and mesh mediated fascial traction will be included in the study in an intention to treat model.

Exclusion criteria:

Treatment of open abdomen with other techniques.

Method:

  • The first period of 2-5 days only the abdominal VAWC dressing is applied.
  • On day 3-10 a polypropylene mesh is sutured to the fascial edges, between the two layers of the VAWC system, and tightened.
  • The VAWC dressing is changed and the mesh tightened every 2-3 days, resulting in gradual approximation of the fascial edges.
  • Finally the mesh is removed and the fascia is closed.
  • At closure the wound to suture length is registered.

Primary endpoint:

Frequency of primary fascial closure.

Secondary endpoints:

  • study of factors associated with failure of fascial closure and in-hospital mortality,
  • abdominal pressure variation attributable to the use of the technique,
  • duration of treatment with open abdomen,
  • frequency of incisional hernia after one and five years.

Duration of the study:

3-5 years. Enrollment of open abdomen cases.

Follow-up schedule for patients:

  • Clinical evaluation at 1 and 5 years.
  • CT-examination at 1 year.
02

Conditions studied

  • Open Abdomen
  • Fascial Closure

Keywords

  • Open abdomen
  • Fascial closure
  • Vacuum assisted wound closure
  • Mesh
  • Abdominal compartment syndrome
  • Intraabdominal pressure
  • Incisional hernia
03

In context

Lead sponsor

Skane University Hospital is the lead sponsor of 71 studies on the registry; 17 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • open abdomen patients with midline incisions, where vacuum assisted wound closure system and mesh mediated fascial traction is applicable

Exclusion criteria

Exclusion Criteria:

  • open abdomen patients treated otherwise
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
111 participants (actual)

Study arms

  • Other
    VAWC and mesh mediated fascial traction

    This is a study aiming to evaluate one technique for temporary abdominal closure for open abdomen therapy in all patients applicable according to the inclusion criteria

    Procedure: VAWC and mesh mediated fascial traction

Interventions

  • ProcedureVAWC and mesh mediated fascial traction

    The first period of 2-5 days only the abdominal VAWC dressing is applied. On day 3-10 a polypropylene mesh is sutured to the fascial edges, between the two layers of the VAWC system, and tightened. The VAWC dressing is changed and the mesh tightened every 2-3 days, resulting in gradual approximation of the fascial edges. Finally the mesh is removed and the fascia is closed

06

What researchers measure

Primary outcomes

  1. Primary fascial closure rate

    Primary fascial closure rate with the technique

    Time frame: 2 months

Secondary outcomes

  1. Factors associated with failure of fascial closure and in-hospital mortality, abdominal pressure, duration of treatment with open abdomen, frequency of incisional hernia development

    Early, intermediate and late outcomes

    Time frame: 5 years

07

Study locations

5 sites
  • Department of Surgery, Falu Hospital
    Falun, 791 82, Sweden
  • Department of Surgery, Gävle Hospital
    Gävle, 801 87, Sweden
  • Department of Surgery, Malmö University Hospital
    Malmö, 205 02, Sweden
  • Department of Vascular Surgery, Malmö University Hospital
    Malmö, 205 02, Sweden
  • Department of Surgery, Uppsala University Hospital
    Uppsala, 751 85, Sweden
08

References and documents

Publications

  • Bjarnason T, Montgomery A, Ekberg O, Acosta S, Svensson M, Wanhainen A, Bjorck M, Petersson U. One-year follow-up after open abdomen therapy with vacuum-assisted wound closure and mesh-mediated fascial traction. World J Surg. 2013 Sep;37(9):2031-8. doi: 10.1007/s00268-013-2082-x. PubMed 23703638 ↗
  • Sorelius K, Wanhainen A, Acosta S, Svensson M, Djavani-Gidlund K, Bjorck M. Open abdomen treatment after aortic aneurysm repair with vacuum-assisted wound closure and mesh-mediated fascial traction. Eur J Vasc Endovasc Surg. 2013 Jun;45(6):588-94. doi: 10.1016/j.ejvs.2013.01.041. Epub 2013 Mar 1. PubMed 23465456 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 29, 2017, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00494793
Lead sponsor
Skane University Hospital
Collaborators
Uppsala University Hospital, Gävle Hospital, Falu Hospital, KCI Europe Holding B.V., The Swedish Research Council
Responsible party
Ulf Petersson (MD, PhD, Ass prof, Skane University Hospital) — Principal investigator
First posted
Jul 2, 2007
Start date
Apr 1, 2006
Primary completion
Aug 31, 2009
Completion
Apr 1, 2015
Last update
Dec 29, 2017

Study contacts

Ulf Petersson, MD, PhD
principal investigator · Department of Surgery, Malmö University Hospital, Sweden

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2017. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion